Fintech Festival and the Singapore Week of Innovation and Technology to feature world’s 24-hour hybrid digital and physical event

   2020-12-02 09:12

GlobeNewswire

Global Biopharmaceutical Logistics Industry

Global Biopharmaceutical Logistics Market to Reach $109. 7 Billion by 2027. Amid the COVID-19 crisis, the global market for Biopharmaceutical Logistics estimated at US$78. 8 Billion in the year 2020, is projected to reach a revised size of US$109.New York, Dec. 02, 2020 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report “Global Biopharmaceutical Logistics Industry” – https://www.reportlinker.com/p05960814/?utm_source=GNW 7 Billion by 2027, growing at aCAGR of 4.8% over the period 2020-2027. Cold Chain Logistics, one of the segments analyzed in the report, is projected to record 5.3% CAGR and reach US$29.2 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Non-cold Chain Logistics segment is readjusted to a revised 4.7% CAGR for the next 7-year period. The U.S. Market is Estimated at $23.2 Billion, While China is Forecast to Grow at 4.5% CAGR The Biopharmaceutical Logistics market in the U.S. is estimated at US$23.2 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$19.4 Billion by the year 2027 trailing a CAGR of 4.5% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.7% and 3.8% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.9% CAGR.We bring years of research experience to this 7th edition of our report. The 170-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed. Competitors identified in this market include, among others, * AmerisourceBergen Corporation * DB Schenker * DHL Express Germany GmbH * FedEx Corporation * United Parcel Service, Inc. (UPS) Read the full report: https://www.reportlinker.com/p05960814/?utm_source=GNW I. INTRODUCTION, METHODOLOGY & REPORT SCOPE II. EXECUTIVE SUMMARY 1. MARKET OVERVIEW Global Competitor Market Shares Biopharmaceutical Logistics Competitor Market Share Scenario Worldwide (in %): 2019 & 2025 Impact of Covid-19 and a Looming Global Recession 2. FOCUS ON SELECT PLAYERS 3. MARKET TRENDS & DRIVERS 4. GLOBAL MARKET PERSPECTIVE Table 1: World Current & Future Analysis for Biopharmaceutical Logistics by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets – Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 Table 2: World Historic Review for Biopharmaceutical Logistics by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 Table 3: World 15-Year Perspective for Biopharmaceutical Logistics by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027 Table 4: World Current & Future Analysis for Cold Chain Logistics by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets – Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 Table 5: World Historic Review for Cold Chain Logistics by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 Table 6: World 15-Year Perspective for Cold Chain Logistics by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 Table 7: World Current & Future Analysis for Non-cold Chain Logistics by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets – Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 Table 8: World Historic Review for Non-cold Chain Logistics by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 Table 9: World 15-Year Perspective for Non-cold Chain Logistics by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 Table 10: World Current & Future Analysis for Transportation by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets – Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 Table 11: World Historic Review for Transportation by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 Table 12: World 15-Year Perspective for Transportation by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 Table 13: World Current & Future Analysis for Warehousing by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets – Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 Table 14: World Historic Review for Warehousing by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 Table 15: World 15-Year Perspective for Warehousing by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 III. MARKET ANALYSIS GEOGRAPHIC MARKET ANALYSIS UNITED STATES Market Facts & Figures US Biopharmaceutical Logistics Market Share (in %) by Company: 2019 & 2025 Market Analytics Table 16: USA Current & Future Analysis for Biopharmaceutical Logistics by Type – Cold Chain Logistics and Non-cold Chain Logistics – Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 Table 17: USA Historic Review for Biopharmaceutical Logistics by Type – Cold Chain Logistics and Non-cold Chain Logistics Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 Table 18: USA 15-Year Perspective for Biopharmaceutical Logistics by Type – Percentage Breakdown of Value Sales for Cold Chain Logistics and Non-cold Chain Logistics for the Years 2012, 2020 & 2027 Table 19: USA Current & Future Analysis for Biopharmaceutical Logistics by Service – Transportation and Warehousing – Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 Table 20: USA Historic Review for Biopharmaceutical Logistics by Service – Transportation and Warehousing Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 Table 21: USA 15-Year Perspective for Biopharmaceutical Logistics by Service – Percentage Breakdown of Value Sales for Transportation and Warehousing for the Years 2012, 2020 & 2027 CANADA Table 22: Canada Current & Future Analysis for Biopharmaceutical Logistics by Type – Cold Chain Logistics and Non-cold Chain Logistics – Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 Table 23: Canada Historic Review for Biopharmaceutical Logistics by Type – Cold Chain Logistics and Non-cold Chain Logistics Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 Table 24: Canada 15-Year Perspective for Biopharmaceutical Logistics by Type – Percentage Breakdown of Value Sales for Cold Chain Logistics and Non-cold Chain Logistics for the Years 2012, 2020 & 2027 Table 25: Canada Current & Future Analysis for Biopharmaceutical Logistics by Service – Transportation and Warehousing – Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 Table 26: Canada Historic Review for Biopharmaceutical Logistics by Service – Transportation and Warehousing Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 Table 27: Canada 15-Year Perspective for Biopharmaceutical Logistics by Service – Percentage Breakdown of Value Sales for Transportation and Warehousing for the Years 2012, 2020 & 2027 JAPAN Table 28: Japan Current & Future Analysis for Biopharmaceutical Logistics by Type – Cold Chain Logistics and Non-cold Chain Logistics – Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 Table 29: Japan Historic Review for Biopharmaceutical Logistics by Type – Cold Chain Logistics and Non-cold Chain Logistics Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 Table 30: Japan 15-Year Perspective for Biopharmaceutical Logistics by Type – Percentage Breakdown of Value Sales for Cold Chain Logistics and Non-cold Chain Logistics for the Years 2012, 2020 & 2027 Table 31: Japan Current & Future Analysis for Biopharmaceutical Logistics by Service – Transportation and Warehousing – Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 Table 32: Japan Historic Review for Biopharmaceutical Logistics by Service – Transportation and Warehousing Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 Table 33: Japan 15-Year Perspective for Biopharmaceutical Logistics by Service – Percentage Breakdown of Value Sales for Transportation and Warehousing for the Years 2012, 2020 & 2027 CHINA Table 34: China Current & Future Analysis for Biopharmaceutical Logistics by Type – Cold Chain Logistics and Non-cold Chain Logistics – Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 Table 35: China Historic Review for Biopharmaceutical Logistics by Type – Cold Chain Logistics and Non-cold Chain Logistics Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 Table 36: China 15-Year Perspective for Biopharmaceutical Logistics by Type – Percentage Breakdown of Value Sales for Cold Chain Logistics and Non-cold Chain Logistics for the Years 2012, 2020 & 2027 Table 37: China Current & Future Analysis for Biopharmaceutical Logistics by Service – Transportation and Warehousing – Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 Table 38: China Historic Review for Biopharmaceutical Logistics by Service – Transportation and Warehousing Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 Table 39: China 15-Year Perspective for Biopharmaceutical Logistics by Service – Percentage Breakdown of Value Sales for Transportation and Warehousing for the Years 2012, 2020 & 2027 EUROPE Market Facts & Figures European Biopharmaceutical Logistics Market: Competitor Market Share Scenario (in %) for 2019 & 2025 Market Analytics Table 40: Europe Current & Future Analysis for Biopharmaceutical Logistics by Geographic Region – France, Germany, Italy, UK and Rest of Europe Markets – Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 Table 41: Europe Historic Review for Biopharmaceutical Logistics by Geographic Region – France, Germany, Italy, UK and Rest of Europe Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 Table 42: Europe 15-Year Perspective for Biopharmaceutical Logistics by Geographic Region – Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027 Table 43: Europe Current & Future Analysis for Biopharmaceutical Logistics by Type – Cold Chain Logistics and Non-cold Chain Logistics – Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 Table 44: Europe Historic Review for Biopharmaceutical Logistics by Type – Cold Chain Logistics and Non-cold Chain Logistics Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 Table 45: Europe 15-Year Perspective for Biopharmaceutical Logistics by Type – Percentage Breakdown of Value Sales for Cold Chain Logistics and Non-cold Chain Logistics for the Years 2012, 2020 & 2027 Table 46: Europe Current & Future Analysis for Biopharmaceutical Logistics by Service – Transportation and Warehousing – Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 Table 47: Europe Historic Review for Biopharmaceutical Logistics by Service – Transportation and Warehousing Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 Table 48: Europe 15-Year Perspective for Biopharmaceutical Logistics by Service – Percentage Breakdown of Value Sales for Transportation and Warehousing for the Years 2012, 2020 & 2027 FRANCE Table 49: France Current & Future Analysis for Biopharmaceutical Logistics by Type – Cold Chain Logistics and Non-cold Chain Logistics – Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 Table 50: France Historic Review for Biopharmaceutical Logistics by Type – Cold Chain Logistics and Non-cold Chain Logistics Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 Table 51: France 15-Year Perspective for Biopharmaceutical Logistics by Type – Percentage Breakdown of Value Sales for Cold Chain Logistics and Non-cold Chain Logistics for the Years 2012, 2020 & 2027 Table 52: France Current & Future Analysis for Biopharmaceutical Logistics by Service – Transportation and Warehousing – Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 Table 53: France Historic Review for Biopharmaceutical Logistics by Service – Transportation and Warehousing Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 Table 54: France 15-Year Perspective for Biopharmaceutical Logistics by Service – Percentage Breakdown of Value Sales for Transportation and Warehousing for the Years 2012, 2020 & 2027 GERMANY Table 55: Germany Current & Future Analysis for Biopharmaceutical Logistics by Type – Cold Chain Logistics and Non-cold Chain Logistics – Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 Table 56: Germany Historic Review for Biopharmaceutical Logistics by Type – Cold Chain Logistics and Non-cold Chain Logistics Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 Table 57: Germany 15-Year Perspective for Biopharmaceutical Logistics by Type – Percentage Breakdown of Value Sales for Cold Chain Logistics and Non-cold Chain Logistics for the Years 2012, 2020 & 2027 Table 58: Germany Current & Future Analysis for Biopharmaceutical Logistics by Service – Transportation and Warehousing – Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 Table 59: Germany Historic Review for Biopharmaceutical Logistics by Service – Transportation and Warehousing Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 Table 60: Germany 15-Year Perspective for Biopharmaceutical Logistics by Service – Percentage Breakdown of Value Sales for Transportation and Warehousing for the Years 2012, 2020 & 2027 ITALY Table 61: Italy Current & Future Analysis for Biopharmaceutical Logistics by Type – Cold Chain Logistics and Non-cold Chain Logistics – Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 Table 62: Italy Historic Review for Biopharmaceutical Logistics by Type – Cold Chain Logistics and Non-cold Chain Logistics Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 Table 63: Italy 15-Year Perspective for Biopharmaceutical Logistics by Type – Percentage Breakdown of Value Sales for Cold Chain Logistics and Non-cold Chain Logistics for the Years 2012, 2020 & 2027 Table 64: Italy Current & Future Analysis for Biopharmaceutical Logistics by Service – Transportation and Warehousing – Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 Table 65: Italy Historic Review for Biopharmaceutical Logistics by Service – Transportation and Warehousing Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 Table 66: Italy 15-Year Perspective for Biopharmaceutical Logistics by Service – Percentage Breakdown of Value Sales for Transportation and Warehousing for the Years 2012, 2020 & 2027 UNITED KINGDOM Table 67: UK Current & Future Analysis for Biopharmaceutical Logistics by Type – Cold Chain Logistics and Non-cold Chain Logistics – Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 Table 68: UK Historic Review for Biopharmaceutical Logistics by Type – Cold Chain Logistics and Non-cold Chain Logistics Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 Table 69: UK 15-Year Perspective for Biopharmaceutical Logistics by Type – Percentage Breakdown of Value Sales for Cold Chain Logistics and Non-cold Chain Logistics for the Years 2012, 2020 & 2027 Table 70: UK Current & Future Analysis for Biopharmaceutical Logistics by Service – Transportation and Warehousing – Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 Table 71: UK Historic Review for Biopharmaceutical Logistics by Service – Transportation and Warehousing Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 Table 72: UK 15-Year Perspective for Biopharmaceutical Logistics by Service – Percentage Breakdown of Value Sales for Transportation and Warehousing for the Years 2012, 2020 & 2027 REST OF EUROPE Table 73: Rest of Europe Current & Future Analysis for Biopharmaceutical Logistics by Type – Cold Chain Logistics and Non-cold Chain Logistics – Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 Table 74: Rest of Europe Historic Review for Biopharmaceutical Logistics by Type – Cold Chain Logistics and Non-cold Chain Logistics Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 Table 75: Rest of Europe 15-Year Perspective for Biopharmaceutical Logistics by Type – Percentage Breakdown of Value Sales for Cold Chain Logistics and Non-cold Chain Logistics for the Years 2012, 2020 & 2027 Table 76: Rest of Europe Current & Future Analysis for Biopharmaceutical Logistics by Service – Transportation and Warehousing – Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 Table 77: Rest of Europe Historic Review for Biopharmaceutical Logistics by Service – Transportation and Warehousing Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 Table 78: Rest of Europe 15-Year Perspective for Biopharmaceutical Logistics by Service – Percentage Breakdown of Value Sales for Transportation and Warehousing for the Years 2012, 2020 & 2027 ASIA-PACIFIC Table 79: Asia-Pacific Current & Future Analysis for Biopharmaceutical Logistics by Type – Cold Chain Logistics and Non-cold Chain Logistics – Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 Table 80: Asia-Pacific Historic Review for Biopharmaceutical Logistics by Type – Cold Chain Logistics and Non-cold Chain Logistics Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 Table 81: Asia-Pacific 15-Year Perspective for Biopharmaceutical Logistics by Type – Percentage Breakdown of Value Sales for Cold Chain Logistics and Non-cold Chain Logistics for the Years 2012, 2020 & 2027 Table 82: Asia-Pacific Current & Future Analysis for Biopharmaceutical Logistics by Service – Transportation and Warehousing – Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 Table 83: Asia-Pacific Historic Review for Biopharmaceutical Logistics by Service – Transportation and Warehousing Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 Table 84: Asia-Pacific 15-Year Perspective for Biopharmaceutical Logistics by Service – Percentage Breakdown of Value Sales for Transportation and Warehousing for the Years 2012, 2020 & 2027 REST OF WORLD Table 85: Rest of World Current & Future Analysis for Biopharmaceutical Logistics by Type – Cold Chain Logistics and Non-cold Chain Logistics – Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 Table 86: Rest of World Historic Review for Biopharmaceutical Logistics by Type – Cold Chain Logistics and Non-cold Chain Logistics Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 Table 87: Rest of World 15-Year Perspective for Biopharmaceutical Logistics by Type – Percentage Breakdown of Value Sales for Cold Chain Logistics and Non-cold Chain Logistics for the Years 2012, 2020 & 2027 Table 88: Rest of World Current & Future Analysis for Biopharmaceutical Logistics by Service – Transportation and Warehousing – Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 Table 89: Rest of World Historic Review for Biopharmaceutical Logistics by Service – Transportation and Warehousing Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 Table 90: Rest of World 15-Year Perspective for Biopharmaceutical Logistics by Service – Percentage Breakdown of Value Sales for Transportation and Warehousing for the Years 2012, 2020 & 2027 IV. COMPETITION Total Companies Profiled: 41 Read the full report: https://www.reportlinker.com/p05960814/?utm_source=GNW About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need – instantly, in one place. __________________________ CONTACT: Clare: [email protected] US: (339)-368-6001 Intl: +1 339-368-6001




Original Source


CryptoCurrencyUSDChange 1hChange 24hChange 7d
Bitcoin32,439 1.19 % 5.71 % 13.39 %
Ethereum1,242.5 1.69 % 2.45 % 9.76 %
Tether1.000 0.39 % 0.27 % 0.12 %
Polkadot16.48 0.57 % 8.92 % 49.46 %
XRP0.2839 1.06 % 0.28 % 7.39 %
Cardano0.3445 0.85 % 0.98 % 10.66 %
Litecoin135.34 1.12 % 5.12 % 8.26 %
Bitcoin Cash447.84 1.75 % 6.44 % 9.85 %
Chainlink19.68 1.47 % 0.26 % 23.32 %
Stellar0.2748 0.60 % 3.06 % 9.61 %
Binance Coin39.86 1.54 % 2.42 % 0.90 %
USD Coin1.000 0.55 % 0.09 % 0.06 %
Wrapped Bitcoin32,600 1.19 % 5.03 % 12.70 %
Bitcoin SV188.58 1.25 % 0.25 % 11.39 %
Monero142.08 1.05 % 4.68 % 17.44 %
EOS2.630 1.52 % 3.00 % 5.29 %
VeChain0.03206 0.50 % 2.84 % 22.72 %
Aave169.41 1.86 % 4.46 % 14.78 %
TRON0.02902 0.80 % 1.89 % 3.77 %
Tezos2.650 0.62 % 2.93 % 6.43 %